Medications for Opioid Use Disorder
A plain-language guide to buprenorphine, methadone, naltrexone, access, safety, and continuity.
Medication access and retention are central evidence questions for opioid treatment comparisons.
Buprenorphine, methadone, and naltrexone can treat opioid use disorder. The right option depends on the person, and stopping medication should be a clinical decision rather than a program rule.
Read the claim and the source separately
Medication access and retention are central evidence questions for opioid treatment comparisons. Strong research identifies who produced the evidence, what population it covers, when it was updated, and what the source can actually support.
A precise source with acknowledged limits is more useful than a sweeping claim without a traceable basis.
Turn information into a safer next step
Clarify the need
Define the immediate medical, psychiatric, substance, medication, housing, and support concerns.
Verify the provider
Match the legal operator, location, authorized service, staffing, and advertised claim.
Confirm the pathway
Ask how assessment, treatment, medications, discharge, and aftercare connect.
Document the terms
Keep written benefit, price, exclusion, refund, and admission information.
Verify with authoritative records
FindTreatment.gov for treatment search, SAMHSA National Helpline for information, 988 Suicide and Crisis Lifeline for crisis support, and the relevant state licensing authority for current facility status. Call 911 for immediate danger or a medical emergency.